MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.hrthm.2024.10.057

Медицинская библиотека · Heart rhythm · 2024

Long-term prognosis of patients with an SCN5A loss-of-function variant and progressive cardiac conduction disorder or Brugada syndrome.

Tuijnenburg Fenna, Proost Virginnio M, Thollet Aurélie, Barc Julien, Groffen Alexander J A, Veerman Christiaan C, van der Crabben Saskia N, van der Pas Vincent R, Kyndt Florence, Jurgens Sean J, Tanck Michael W T, Postema Pieter G, Peter van Tintelen J, Bezzina Connie R, Probst Vincent, Wilde Arthur A M, Gourraud Jean-Baptiste, Amin Ahmad S

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The long-term prognosis of patients with a loss-of-function variant in the cardiac sodium channel gene SCN5A is unknown.

OBJECTIVE

This study aimed to evaluate the long-term arrhythmic risk in patients with an SCN5A loss-of-function variant to identify predictors of arrhythmic events.

METHODS

Probands and family members with (likely) pathogenic SCN5A loss-of-function variants were retrospectively included. Clinical and electrocardiographic data at baseline and last follow-up were collected. Patients with a history of cardiac arrest, sustained ventricular tachycardia, symptomatic or documented atrial tachy- or bradyarrhythmia, or arrhythmogenic syncope were categorized as symptomatic. Arrhythmic events at follow-up were defined as sudden death, aborted cardiac arrest, documented ventricular fibrillation, and/or sustained ventricular tachycardia.

RESULTS

We included 615 patients (349 men, 242 probands, 157 with a spontaneous type 1 Brugada electrocardiogram, and 111 symptomatic at baseline). During a median follow-up of 9.5 (Q1,Q3 5.0-14.3) years, arrhythmic events occurred in 41 patients (6.7%), equating an overall event rate of 0.7%/y: 2.0%/y in symptomatic and 0.3%/y in asymptomatic patients. In the overall study population, symptoms at baseline, male sex, and QRS prolongation were identified as independent predictors of arrhythmic events. In asymptomatic patients, male sex and QRS prolongation were also identified as predictors. Asymptomatic women with QRS interval < 100 ms did not experience arrhythmic events at follow-up.

CONCLUSION

Key predictors of arrhythmic risk in patients with an SCN5A loss-of-function variant, regardless of a Brugada syndrome diagnosis, are symptoms at baseline, male sex, and prolonged QRS interval. Our findings may enable more tailored management strategies in patients with an SCN5A loss-of-function variant based on their individual risk profiles.

Для цитирования: Tuijnenburg Fenna, Proost Virginnio M, Thollet Aurélie, Barc Julien, Groffen Alexander J A, Veerman Christiaan C, van der Crabben Saskia N, van der Pas Vincent R, Kyndt Florence, Jurgens Sean J, Tanck Michael W T, Postema Pieter G, Peter van Tintelen J, Bezzina Connie R, Probst Vincent, Wilde Arthur A M, Gourraud Jean-Baptiste, Amin Ahmad S. Long-term prognosis of patients with an SCN5A loss-of-function variant and progressive cardiac conduction disorder or Brugada syndrome.. Heart rhythm. 2024. DOI: 10.1016/j.hrthm.2024.10.057.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.